ReviewBiogerontology2026
G1/S arrest: a key mechanism of cellular aging and replicative senescence.
Review in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quercetin Mitigates Oxidative Stress-Induced Premature Senescence in SH-SY5Y Neuronal-like Cells.International journal of molecular sciences · 2026Article
- Towards a context-aware framework for cellular senescence.Biogerontology · 2026Review
- Tumor-derived circulating DNA can induce senescence and SASP activation in mouse embryonic fibroblasts.Biogerontology · 2026Article
- Development of a novel series of thiazole-based compounds with enhanced antiproliferative properties as tubulin polymerization inhibitors.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Replicative senescence frequently occurs in in vitro cell cultures and certain in vivo pathological conditions, characterized by multiple phenotypes, including cell cycle arrest. Previous studies suggested that the main mechanism underlying replicative senescence is that under continuous subculture, cells sense DNA damage during G1, which triggers G1/S arrest and the subsequent geroconversion. However, this explanation does not account for phenomena such as how DNA damage caused by replication stress in the mother cell directly affects the G1/S transition in the daughter cell. Recent advances in single-cell analysis techniques have enabled more detailed investigation of the G1/S transition process, leading to the development of new models. The updated model extends the window for cells to sense DNA damage from daughter G1 backward to mother G2, significantly prolonging the period during which DNA damage can regulate the G1/S transition. Despite these developments, the mechanistic understanding of replicative senescence has not been comprehensively revised based on the updated model. Therefore, this review systematically elaborates on the key process of G1/S arrest in inducing replicative senescence, based on the existing evidence: DNA damage accumulated during continuous passaging activates the p53-p21 and p16-Rb pathways at different cell cycle stages. The p53-p21 pathway promotes the initiation and progression of replicative senescence by primarily inactivating cyclin-dependent kinase complexes during mother G2 and daughter G1, thereby temporarily arresting the cell cycle. In the final stages of replicative senescence, the p16-Rb pathway predominantly substitutes for p21 to enforce an irreversible cell cycle arrest. The geroconversion process associated with these pathways ultimately facilitates the emergence of diverse senescence phenotypes.
Indexed as
Identifiers
41543765What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.